Clinical Trial Support Services
In recent years, the strength of commercial profit growth has stimulated greater private investment in clinical trials, benefiting the Clinical Trial Support Services industry and increasing its reliance on the private sector. Meanwhile, government austerity measures hurt industry revenue as the federal government sought to reduce debt. Nonetheless, strong investment in clinical studies for oncology and medical devices, as well as increased requirements for trial registration, have helped boost demand for clinical trial support services. Over the next five years, the Clinical Trial Support Services industry is expected to maintain growth, benefiting from greater stability due to consistent funding from private and public sources. Private businesses are expected to increase their R&D budgets as stronger profit encourages companies to invest in product development. Cancer treatment products will continue to be the leading driver of new drugs and are expected to increase demand for support services.
Companies in this industry provide medical clinical trial services. Typically, industry operators provide preclinical trial preparation work, track and record results and prepare data for regulatory submission and data storage.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook